Source: Υπουργείο Υγείας (CY) Revision Year: 2014 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Kratium 10mg/2ml solution for injection/infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection/infusion. Clear, colourless to light yellow solution for injection/infusion. |
Each 2ml of solution contain 10 mg of diazepam.
Excipients with known effect: benzyl alcohol. Each ml of Kratium contains 20 mg benzyl alcohol.
For the full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diazepam |
Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms. |
| List of Excipients |
|---|
|
Propylene glycol EP |
Type I, 2 ml amber ampoules (primary package).
Boxes of 10 ampoules (2 blisters x 5 ampoules) and 100 ampoules (20 blisters x 5 ampoules).
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
20767
29/09/2010
| Drug | Countries | |
|---|---|---|
| KRATIUM | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
